Study of Anaplasmosis Cases in Alsace
Part of Blood & lymphatic, Brain & nervous system, Immune system & allergy, Infections, Injuries & trauma, Lungs & breathing clinical trials.
This study looks at people in Alsace, France, who have been diagnosed with anaplasmosis (a tick-borne infection). It aims to understand the disease's patterns and symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have a confirmed case of anaplasmosis, diagnosed with a PCR test.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at cases of babesiosis, a rare tick-borne disease, in France from 2000 to 2024. It aims to understand how the disease affects people.
This trial asks general practitioners in France to complete a survey about their knowledge of tick-borne encephalitis (a virus spread by ticks that can cause brain swelling). It helps researchers understand how well doctors know about this disease and how to prevent it.
This study looks at how the body reacts to tick bites, specifically to understand alpha-gal syndrome—a condition that can cause allergic reactions to red meat. If you had a recent tick bite and can provide the tick, you may be able to help researchers learn more.
This study looks at how the immune system reacts to the bacteria that cause Lyme disease in people with a skin condition called ACA. It may help doctors understand the disease better and guide future treatments.
This study checks whether a new lab test (a PCR blood/tissue test) can more accurately diagnose echinococcosis. It may help doctors confirm the infection faster and more reliably so you can get the right treatment.
This study looks at people who got a serious form of Lyme disease while being treated with a type of biologic drug called an anti-CD20 (such as rituximab). The goal is to learn more about these cases and improve care. You may join if you had Lyme disease confirmed by a DNA test within two years of taking this medicine.
Hear when a new Human Anaplasmosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.